These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 30609560)

  • 21. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
    Lu N; Xie S; Li J; Tian R; Peng YY
    Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of myeloperoxidase oxidant production by N-acetyl lysyltyrosylcysteine amide reduces brain damage in a murine model of stroke.
    Yu G; Liang Y; Huang Z; Jones DW; Pritchard KA; Zhang H
    J Neuroinflammation; 2016 May; 13(1):119. PubMed ID: 27220420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitosan based substrates for wound infection detection based on increased lysozyme activity.
    Tegl G; Rollett A; Dopplinger J; Gamerith C; Guebitz GM
    Carbohydr Polym; 2016 Oct; 151():260-267. PubMed ID: 27474566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Femtogram detection of horseradish peroxidase by a common desktop scanner.
    Parween S; Nahar P
    J Biosci Bioeng; 2015 Jan; 119(1):113-6. PubMed ID: 25027707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
    Van Antwerpen P; Dufrasne F; Lequeux M; Boudjeltia KZ; Lessgyer I; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Eur J Pharmacol; 2007 Sep; 570(1-3):235-43. PubMed ID: 17610876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of myeloperoxidase-mediated oxidative damage by nitrite in SH-SY5Y cells: Relevance to neuroprotection in neurodegenerative diseases.
    Lu N; Ding Y; Tian R; Peng YY
    Eur J Pharmacol; 2016 Jun; 780():142-7. PubMed ID: 27020551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic characterisation of a dye decolourising peroxidase from Streptomyces lividans: new insight into the mechanism of anthraquinone dye decolourisation.
    Chaplin AK; Wilson MT; Worrall JAR
    Dalton Trans; 2017 Jul; 46(29):9420-9429. PubMed ID: 28695933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidation of glutathione by the myeloperoxidase system.
    Turkall RM; Tsan MF
    J Reticuloendothel Soc; 1982 Apr; 31(4):353-60. PubMed ID: 6286969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients.
    Khalilova IS; Dickerhof N; Mocatta TJ; Bhagra CJ; McClean DR; Obinger C; Kettle AJ
    PLoS One; 2018; 13(3):e0192952. PubMed ID: 29590135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between LDL oxidation and macrophage myeloperoxidase activity.
    Wu J; Liu Y; Li X; Chen L; Xia L; Hong J
    Chin Med J (Engl); 2003 May; 116(5):791-3. PubMed ID: 12875704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric detection of myeloperoxidase in horse neutrophils: a novel technique in equine diagnostic research.
    Wauters J; Franck T; Pille F; Martens A; Demeyere K; Sys S; Serteyn D; Gasthuys F; Meyer E
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):417-22. PubMed ID: 22018886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suicide inactivation of covalent peroxidase-mimicking DNAzyme with hydrogen peroxide and its protection by a reductant substrate.
    Gribas AV; Zatsepin TS; Korolev SP; Gottikh MB; Sakharov IY
    Talanta; 2016 Aug; 155():212-5. PubMed ID: 27216675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agents.
    Maiocchi SL; Morris JC; Rees MD; Thomas SR
    Biochem Pharmacol; 2017 Jul; 135():90-115. PubMed ID: 28344126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of chemical features of potent myeloperoxidase inhibitors.
    Soubhye J; Meyer F; Furtmüller P; Obinger C; Dufrasne F; Antwerpen PV
    Future Med Chem; 2016 Jul; 8(11):1163-77. PubMed ID: 27402298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The control of peroxidase-catalysed iodination and de-iodination.
    van Zyl A; Burger B; Rossouw P; Wilson B
    S Afr Med J; 1981 Aug; 60(5):184-91. PubMed ID: 6266056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The free amino acid tyrosine enhances the chlorinating activity of human myeloperoxidase.
    Vlasova II; Sokolov AV; Arnhold J
    J Inorg Biochem; 2012 Jan; 106(1):76-83. PubMed ID: 22112843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DFT calculations suggest a new type of self-protection and self-inhibition mechanism in the mammalian heme enzyme myeloperoxidase: nucleophilic addition of a functional water rather than one-electron reduction.
    Sicking W; Somnitz H; Schmuck C
    Chemistry; 2012 Aug; 18(35):10937-48. PubMed ID: 22829409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidation of a laccase mediator ABTS as studied by ESI-FTICR mass spectrometry.
    Marjasvaara A; Jänis J; Vainiotalo P
    J Mass Spectrom; 2008 Apr; 43(4):470-7. PubMed ID: 17975855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorimetric cholesterol sensor based on peroxidase like activity of zinc oxide nanoparticles incorporated carbon nanotubes.
    Hayat A; Haider W; Raza Y; Marty JL
    Talanta; 2015 Oct; 143():157-161. PubMed ID: 26078143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox properties of myeloperoxidase.
    Arnhold J; Furtmüller PG; Obinger C
    Redox Rep; 2003; 8(4):179-86. PubMed ID: 14599340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.